Potter Andrew, Gerdts Volker, Littel-van den Hurk Sylvia van Drunen
Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, 120 Veterinary Road, Saskatoon, SK S7N5E3, Canada.
Anim Health Res Rev. 2008 Dec;9(2):187-99. doi: 10.1017/S1466252308001606.
The prevention of infectious diseases of animals by vaccination has been routinely practiced for decades and has proved to be one of the most cost-effective methods of disease control. However, since the pioneering work of Pasteur in the 1880s, the composition of veterinary vaccines has changed very little from a conceptual perspective and this has, in turn, limited their application in areas such as the control of chronic infectious diseases. New technologies in the areas of vaccine formulation and delivery as well as our increased knowledge of disease pathogenesis and the host responses associated with protection from disease offer promising alternatives for vaccine formulation as well as targets for the prevention of bacterial disease. These new vaccines have the potential to lessen our reliance on antibiotics for disease control, but will only reach their full potential when used in combination with other intervention strategies.
通过接种疫苗预防动物传染病已常规实施数十年,并且已证明是疾病控制最具成本效益的方法之一。然而,自19世纪80年代巴斯德的开创性工作以来,从概念角度来看,兽用疫苗的成分变化甚微,这反过来又限制了它们在慢性传染病控制等领域的应用。疫苗配方和递送领域的新技术,以及我们对疾病发病机制和与疾病预防相关的宿主反应的更多了解,为疫苗配方提供了有前景的替代方案以及预防细菌性疾病的靶点。这些新型疫苗有可能减少我们对使用抗生素控制疾病的依赖,但只有与其他干预策略联合使用时才能充分发挥其潜力。